Publikationen (149) Publikationen von MARIO DELGADO MORA

filter_list

2009

  1. Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses

    Gastroenterology, Vol. 136, Núm. 3, pp. 978-989

  2. Generating tolerogenic dendritic cells with neuropeptides

    Human Immunology, Vol. 70, Núm. 5, pp. 300-307

  3. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

    Gut, Vol. 58, Núm. 7, pp. 929-939

  4. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death

    Cell Death and Differentiation, Vol. 16, Núm. 3, pp. 406-416

  5. Requirement of IFN-γ-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells

    Tissue Engineering - Part A, Vol. 15, Núm. 10, pp. 2795-2806

  6. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

    Arthritis and Rheumatism, Vol. 60, Núm. 4, pp. 1006-1019

2008

  1. Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents

    Brain, Behavior, and Immunity, Vol. 22, Núm. 8, pp. 1146-1151

  2. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders

    Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 135-140

  3. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: A new therapeutic approach for immune disorders

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 5B, pp. 1830-1847

  4. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019

  5. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria

    Journal of Immunology, Vol. 180, Núm. 12, pp. 8369-8377

  6. Immunotherapy for neurological diseases

    Clinical Immunology

  7. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037

  8. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 9, pp. 1235-1241

  9. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study

    World Journal of Gastroenterology, Vol. 14, Núm. 18, pp. 2851-2857

  10. Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1

    American Journal of Pathology, Vol. 172, Núm. 5, pp. 1297-1302

  11. Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells

    Brain, Behavior, and Immunity, Vol. 22, Núm. 1, pp. 35-41

  12. Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels

    GLIA, Vol. 56, Núm. 10, pp. 1091-1103

2007

  1. Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells

    American Journal of Pathology, Vol. 170, Núm. 1, pp. 263-271

  2. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

    Trends in Pharmacological Sciences, Vol. 28, Núm. 9, pp. 482-491